These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15144220)

  • 1. Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione.
    Henderson MC; Krueger SK; Stevens JF; Williams DE
    Chem Res Toxicol; 2004 May; 17(5):633-40. PubMed ID: 15144220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones.
    Henderson MC; Siddens LK; Krueger SK; Stevens JF; Kedzie K; Fang WK; Heidelbaugh T; Nguyen P; Chow K; Garst M; Gil D; Williams DE
    Toxicol Appl Pharmacol; 2014 Jul; 278(2):91-9. PubMed ID: 24727368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes.
    Henderson MC; Siddens LK; Morré JT; Krueger SK; Williams DE
    Toxicol Appl Pharmacol; 2008 Dec; 233(3):420-7. PubMed ID: 18930751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-oxygenation of the thioether organophosphate insecticides phorate and disulfoton by human lung flavin-containing monooxygenase 2.
    Henderson MC; Krueger SK; Siddens LK; Stevens JF; Williams DE
    Biochem Pharmacol; 2004 Sep; 68(5):959-67. PubMed ID: 15294458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of flavin-containing monooxygenase (FMO).
    Krueger SK; Williams DE; Yueh MF; Martin SR; Hines RN; Raucy JL; Dolphin CT; Shephard EA; Phillips IR
    Drug Metab Rev; 2002 Aug; 34(3):523-32. PubMed ID: 12214664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes.
    Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP
    Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide.
    Siddens LK; Krueger SK; Henderson MC; Williams DE
    Biochem Pharmacol; 2014 May; 89(1):141-7. PubMed ID: 24561181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Oxygenation of N-substituted thioureas catalyzed by the pig liver microsomal FAD-containing monooxygenase.
    Poulsen LL; Hyslop RM; Ziegler DM
    Arch Biochem Biophys; 1979 Nov; 198(1):78-88. PubMed ID: 507850
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3.
    Qian L; Ortiz de Montellano PR
    Chem Res Toxicol; 2006 Mar; 19(3):443-9. PubMed ID: 16544950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide.
    Francois AA; Nishida CR; de Montellano PR; Phillips IR; Shephard EA
    Drug Metab Dispos; 2009 Jan; 37(1):178-86. PubMed ID: 18948378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1.
    Kim YM; Ziegler DM
    Drug Metab Dispos; 2000 Aug; 28(8):1003-6. PubMed ID: 10901713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfenic acids as reactive intermediates in xenobiotic metabolism.
    Mansuy D; Dansette PM
    Arch Biochem Biophys; 2011 Mar; 507(1):174-85. PubMed ID: 20869346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective S-oxygenation of 2-aryl-1,3-dithiolanes by rabbit lung enzyme preparations.
    Cashman JR; Williams DE
    Mol Pharmacol; 1990 Feb; 37(2):333-9. PubMed ID: 2304456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and fate of a sulfenic acid intermediate in the metabolic activation of the antithrombotic prodrug prasugrel.
    Dansette PM; Thébault S; Bertho G; Mansuy D
    Chem Res Toxicol; 2010 Jul; 23(7):1268-74. PubMed ID: 20557086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
    Boerma JS; Vermeulen NP; Commandeur JN
    Chem Biol Interact; 2014 Jan; 207():32-40. PubMed ID: 24246759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased biliary GSSG efflux from rat livers perfused with thiocarbamide substrates for the flavin-containing monooxygenase.
    Krieter PA; Ziegler DM; Hill KE; Burk RF
    Mol Pharmacol; 1984 Jul; 26(1):122-7. PubMed ID: 6431260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices.
    Onderwater RC; Commandeur JN; Vermeulen NP
    Toxicology; 2004 Apr; 197(2):81-91. PubMed ID: 15003319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic oxidative cleavage of thioesters: evidence for the formation of sulfenic acid intermediates in the bioactivation of the antithrombotic prodrugs ticlopidine and clopidogrel.
    Dansette PM; Libraire J; Bertho G; Mansuy D
    Chem Res Toxicol; 2009 Feb; 22(2):369-73. PubMed ID: 19170597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver microsome and flavin-containing monooxygenase catalyzed oxidation of organic selenium compounds.
    Chen GP; Ziegler DM
    Arch Biochem Biophys; 1994 Aug; 312(2):566-72. PubMed ID: 8037472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and reactions of sulfenic acid in human serum albumin.
    Alvarez B; Carballal S; Turell L; Radi R
    Methods Enzymol; 2010; 473():117-36. PubMed ID: 20513474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.